Summary
Updated Aug 31, 2026
Ron Martell is President, CEO and Director, Director of Jasper Therapeutics, Inc. (JSPR). 3 SEC Form 4 filings on record going back to 2025, most recently on 6 January 2026. Most recent open-market trade: bought $100K of JSPR on 24 September 2025. Lifetime open-market purchases: $100K.
Recent Transactions
1Every recent SEC Form 4 transaction Ron Martell has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Ron Martell files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Thomas G. Wiggans - $100K of JSPR open-market activity in the last 12 months
- Judith Anne Shizuru - $100K of JSPR open-market activity in the last 12 months
- Svetlana Lucas - $49K of JSPR open-market activity in the last 12 months
- Patrick J. Crutcher - of JSPR open-market activity in the last 12 months
- Matthew E. Ros - of JSPR open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Ron Martell?
Ron Martell is a corporate insider, tracked as President, CEO and Director, Director of Jasper Therapeutics, Inc. (JSPR). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Ron Martell last file a Form 4?
The most recent primary Form 4 on record is dated 6 January 2026, one of 3 filings going back to 2025.
Has Ron Martell been buying or selling stock?
Recorded transactions: 2 open-market purchases ($100K) and 0 open-market sales across all tracked filings.
Where can I see all of Ron Martell's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Ron Martell and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
